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Abstract
Laminin-5 chain was localized in all epithelial basement membranes (BMs) of mouse submandibular gland (SMG) from the onset of
branching morphogenesis and became restricted to BMs of epithelial ducts in the adult. To investigate whether the laminin-5 chain plays
a role in branching morphogenesis, a set of cell-adhesive peptides from the C-terminal globular domains (LG1-5) was tested for their effects
in SMG organ cultures. One peptide, LVLFLNHGH (A5G77f), which represents a sequence located in the connecting loop between strands
E and F of LG4, perturbed branching morphogenesis and resulted in irregularities in the contours of epithelial structures, with formation
of deep clefts. The data suggest a role for the laminin-5 LG4 module in the development of the duct system, rather than in the bifurcation
of epithelial clusters. The epithelial BM of A5G77f-peptide-treated explants was continuous, which was in contrast to our previous finding
of impaired epithelial BM assembly in explants treated with the laminin-1 LG4 module peptide, or with a monoclonal antibody against
this domain. A5G77f also perturbed in vitro development of lung and kidney. These results suggest a crucial role for the LG4 module of
laminin-5 in epithelial morphogenesis that is distinct from that of the laminin-1 LG4.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Submandibular glands (SMG) of developing mouse and
rat are classic and well-described systems for studying
branching morphogenesis (Borghese, 1950; Grobstein,
1953). The earliest rudimentary SMG epithelium consists of
a large cell cluster connected distally to a stalk. As a result
of repetitive bifurcations of the cluster, a tree-like duct
system forms, the distal ends of which terminate in end
buds. The duct system further differentiates along the prox-
imal–distal axis, resulting in the excretory duct, striated
duct, granular convoluted tubule (GCT) (Gresik, 1994), and
intercalated duct (Pinkstaff, 1979). The end buds differen-
tiate into acini, comprised of well-polarized secretory cells.
The developing SMG exhibits a spaciotemporal expres-
sion of various growth factors (Jaskoll and Melnick, 1999),
including EGF and FGF, which have been shown in organ
culture studies (Kashimata et al., 2000; Morita and Nogawa,
1999; Nogawa and Takahashi, 1991) and in investigations
of genetically mutated mice (Celli et al., 1998; De Moer-
looze et al., 2000; Jaskoll and Melnick, 1999; Ohuchi et al.,
2000) to be essential for development. In addition to these
soluble factors, direct involvement of extracellular matrix
(ECM) molecules (Nakanishi et al., 1986), in particular
those of basement membranes (Bernfield et al., 1984; Ta-
kahashi and Nogawa, 1991), has been implicated in SMG
development. However, studies on the molecular basis of
the effects of individual basement membrane molecules on
SMG development are limited.
The laminin family of basement membrane proteins con-
sists of 15 isoforms (Colognato and Yurchenco, 2000;
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Libby et al., 2000). Specific antibodies against various lami-
nin isoforms have been established and have been employed
in immunohistochemistry to define the in vivo localization
of several laminins during mouse development (Lefebvre et
al., 1999; Miner et al., 1997; Salmivirta et al., 1997; Sorokin
et al., 1992, 1997a,b), including SMG (Kadoya et al., 1995,
1998; Kadoya and Yamashina 1999). Such studies have
revealed a developmentally regulated expression patterns
and suggest roles for laminin isoforms in the development
of several organs (Ekblom et al., 1998; Sorokin and Ek-
blom, 1992).
Laminins are large cross- or Y-shaped glycoproteins
composed of an , , and  chain (Sasaki and Timpl, 1999).
Three or two short arms and one long arm have been
identified by electron microscopy. Various biological activ-
ities of laminins, such as cell adhesion, spreading, migra-
tion, and cell growth (Colognato and Yurchenco, 2000),
have been mapped to distinct structural domains (Martin et
al., 1996) or amino acid sequences (Makino et al., 1999).
The short arms are composed of the amino-terminal ends of
, , and  chains, and have been shown to mediate laminin
polymerization (Garbe et al., 2002; Yurchenco and Cheng,
1993). In contrast, the long arm is composed of the carbox-
yl-terminal end of the  chain and is involved in the binding
to cellular receptors. The best analyzed domain of the lami-
nins is the most distal end of the long arm, the G domain
(Timpl et al., 2000). Sequence analysis indicates that the G
domain consists of a tandem repeat of five LG modules
(LG1-5). LG modules of some laminin  chains, if not all,
have been found to bind cell surface molecules, such as
integrins (Aumailley et al., 1996), syndecans (Salmivirta et
al., 1994), -dystroglycan (Ervasti and Campbell, 1993;
Talts et al., 1999), and the Lutheran blood group glycopro-
tein (Kikkawa et al., 2002; Moulson et al., 2001). Recently,
we identified more than 20 cell-adhesive peptide sequences
by systematic screening of an overlapping synthetic peptide
library covering the entire G domain sequences of laminin-
1, -4, and -5 (Makino et al., 2002; Nomizu et al., 1995;
Okazaki et al., 2002), and LG4 of laminin-3 (Utani et al.,
2001). Of these sequences, the laminin-1 peptides have
been systematically screened for their ability to interfere
with morphogenesis of SMG and hair follicles in organ
cultures. A synthetic peptide, RKRLQVQLSIRT (residues
2719–2730 of laminin-1 chain LG4 module and desig-
nated AG73), was found to inhibit epithelial morphogenesis
(Hayashi et al., 2002; Hoffman et al., 2001; Hosokawa et
al., 1999; Kadoya et al., 1998).
In the present study, we have examined the distribution
of the laminin-5 chain in the developing SMG. Compari-
sons have been made with other laminin  chains (Kadoya
et al., 1995, 1998; Kadoya and Yamashina, 1999), revealing
colocalization of laminin-1 and -5 in epithelial basement
membranes from the onset of SMG formation. Laminin-5
G domain peptides were tested for their ability to interfere
with epithelial cell development in the SMG organ culture
system. Sixteen different peptides were tested, resulting in
the identification of one peptide sequence, LVLFLNHGH-
FVA (residues 3307–3318 and designated A5G77), which
strongly inhibited in vitro organ development. The activity
was restricted to LVLFLNHGH, a 9-amino-acid carboxyl-
terminal deletion sequence (designated A5G77f). The mor-
phology of A5G77f-treated SMG explants was compared
with that of explants treated with AG73 (Kadoya et al.,
1998), anti--dystroglycan antibody (Durbeej et al., 2001),
or a monoclonal antibody against the laminin-1 LG4 mod-
ule (Kadoya et al., 1995).
Materials and methods
Tissues and organ culture
Pregnant ICR mice were purchased from SLC
(Hamamatsu, Japan). The morning of the discovery of a
vaginal plug was designated day 0 (E0). Tissues were dis-
sected from embryonic, newborn, and adult mice under
ether anesthesia. For organ cultures, rudiments of E13
SMG, E12 kidney (metanephros), or E11 lung were placed
on a polycarbonate filtration membrane (pore size 0.05 m;
Nucleopore, Whatman, Clifton, NJ) at the air-medium in-
terface. Cultures were carried out in Improved MEM Zinc
Option or D-MEM/F12 (both from GIBCO, Grand Island,
NY), supplemented with 50 g/ml transferrin but without
serum as described previously (Kadoya et al., 1995, 1998).
Laminin-5 LG module peptides were dissolved in distilled
water at 5 mg/ml and added to the culture medium at a final
concentration of 0.19 mM, unless otherwise stated. After 3
days without a medium change, explants were photo-
graphed under the microscope. To compare the degree of
epithelial branching, the numbers of terminal end buds, air
way sacs, and metanephric vesicles were counted for SMG,
lung, and kidney, respectively. Six to 20 explants were
utilized for each peptide concentration.
Histology and electron microscopy
Explants were fixed in 2.5% glutaraldehyde in 0.1 M
phosphate buffer (pH 7.2), postfixed in 1% OsO4 in the
same buffer, and processed as described previously (Kadoya
and Yamashina, 1991). Sections of 1 m were cut and
stained with 1% toluidine blue aqueous solution. Ultrathin
sections were cut and stained with both lead citrate and
uranyl acetate, and examined under an electron microscope
(1200EX; JEOL, Tokyo, Japan).
Immunofluorescence
Tissues were embedded in OCT compound (Miles,
Elkhart, IN) and immediately frozen in liquid nitrogen.
Frozen sections of 5 m were cut and fixed with methanol.
After blocking with 1% bovine serum albumin (BSA) dis-
solved in phosphate-buffered saline (PBS) for 1 h, sections
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were incubated with culture supernatant of the hybridoma
producing anti-laminin-5 rat IgG (4G6; Sorokin et al.,
1997b). Bound antibodies were visualized by using DTAF-
labeled anti-rat IgG antibody (Chemicon, Temecula, CA),
diluted 1:100 in 1% BSA in PBS. For whole-mount immu-
nofluorescence staining for nidogen, explants were fixed
with Zamboni’s fixative (4% formaldehyde and 0.2% picric
acid in 0.1 M phosphate buffer, pH 7.2), blocked for 1 h
with PBS containing 1% BSA and 0.05% Tween 20, incu-
bated overnight with a rat monoclonal antibody against
nidogen (ELM-1; Upstate Biotechnology, Lake Placid,
NY), diluted 1:100 in 1% BSA in PBS, washed with PBS
containing 0.05% Tween 20 (30 min  3 times), and again
incubated overnight with DTAF-labeled secondary antibody
diluted 1:100 in 1% BSA in PBS. After washing with PBS
containing 0.05% Tween 20 (30 min  3 times), specimens
were mounted in Permafluore (Shandon, Pittsburgh, PA).
All specimens were examined under the confocal scanning
microscope (MRC 1024; Bio-Rad, Hertfordshire, England).
Adhesion assay
HT1080, a human fibrosarcoma cell line, was cultured in
DMEM (GIBCO, Invitrogen, Carlsbad, CA) supplemented
with 10% fetal bovine serum. For cell attachment assays, 10
g of each peptide was coated onto 96-well plates and air
dried. HT1080 cells were plated in the peptide-coated wells
under serum-free conditions, and the number of attached
cells after 1 h incubation at 37°C was determined as de-
scribed previously (Makino et al., 2002). In all cases, pep-
tide activities were evaluated relative to the activity ob-
served with C16, a laminin-1 chain N-terminal domain VI
peptide, previously shown to support HT1080 cell adhesion
(Nomizu et al., 1997).
Peptides
Tables 1 and 2 show laminin peptides tested in the
present study. All sequences were of mouse origin (Makino
et al., 2002; Okazaki et al., 2002), with the exception of
A3G75, which was derived from the human laminin-3
chain sequence (Utani et al., 2001). All peptides were man-
ually synthesized by the 9-fluorenyl-methoxycarbonyl
(Fmoc)-based solid-phase strategy and prepared as the car-
boxyl-terminal amide form; subsequent purification in-
volved reverse phase high performance liquid chromatog-
raphy (Nomizu et al., 1995). Purity and identity of the
peptides were confirmed by using analytical, reverse-phase
high performance liquid chromatography, and mass spec-
troscopy, respectively. Throughout the text, amino acids are
given in the single letter code.
Results
Localization of laminin-5 chain in epithelial basement
membranes of SMG rudiments at the onset of branching
morphogenesis
In E13 embryos, SMG rudiments consist of several large
epithelial clusters connected to an epithelial stalk and sur-
rounded by mesenchyme. The laminin-5 chain was clearly
detected throughout basement membranes of both the epi-
thelial clusters and the stalk (Fig. 1A). No expression was
seen in capillary basement membranes or in the mesen-
Table 1
Synthetic G domain peptides
Peptide Sequencea Chain Modules
A5G3 GKNTGDHFVLYM 5 LG1
A5G26 RFDQELRLVSYN 5 LG2
A5G27 RLVSYNGIIFFLK 5 LG2
A5G33 ASKAIQVFLLAG 5 LG2
A5G35 VLVRVERATVFS 5 LG2
A5G64 VFDLHQNMGSVN 5 LG3
A5G65 HQNMGSVNVSVG 5 LG3
A5G71 GPLPSYLQFVGI 5 LG4
A5G73 RNRLHLSMLVRP 5 LG4
A5G76 APMSGRSPSLVLF 5 LG4
A5G77 LVLFLNHGHFVA 5 LG4
A5G81 AGQWHRVSVRWG 5 LG4
A5G82 VRWGMQQIQLVV 5 LG4
A5G99 VLLQANDGAGEF 5 LG5
A5G101 DGRWHRVAVIMG 5 LG5
A5G112 KQGKALTQRHAK 5 LG5
AG76.5 ATLQLQEGRLHFb 1 LG4
A3G75 KNSFMALYLSKGc 3 LG4
A4G82 TLFLAHGRLVFMd 4 LG4
a Sequences of the synthetic peptides are given in the single-letter code.
All peptides have carboxyl-terminal amides. See Makino et al. (2002) for
residues.
b Mouse laminin-1 chain, residues 2749–2760 (Sasaki et al., 1988).
c Human laminin-3 chain, residues 1411–1422 (Ryan et al., 1994).
d Mouse laminin-4 chain, residues 1514–1525 (Iivanainen et al., 1997).
Table 2
Cell binding activity of amino- and carboxyl-terminal, truncated peptides
of the A5G77
Peptide Sequencea HT-1080 cells
attachment activityb
A5G77 LVLFLNHGHFVA 
A5G77a VLFLNHGHFVA 
A5G77b LFLNHGHFVA 
A5G77c FLNHGHFVA 
A5G77d LVLFLNHGHFV 
A5G77e LVLFLNHGHF 
A5G77f LVLFLNHGH 
A5G77fT LNGVLHHLF 
C16 KAFDITYVRLKF 
a Sequences of the synthetic peptides are given in the single-letter code.
All peptides have carboxyl-terminal amides.
b Activity was scored on the following subjective scale:, adhesion
comparable to that of C16; , weak adhesion compared with that on
C16; , very weak adhesion compared with that on C16; , no adhesion.
Triplicate experiments gave similar results.
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chyme. In newborn mice, a well-branched duct system con-
sisting of polarized epithelial cells and ending in the acini
was apparent. Laminin-5 occurred in basement mem-
branes of interlobular and intralobular ducts (Fig. 1B). In
adult mice (Fig. 1C), the SMG epithelium has differentiated
into distinct segments: acinus, intercalated duct, granular
convoluted tubule (GCT), striated duct, and excretory duct
(Pinkstaff, 1979). Laminin-5 chain was detected in base-
ment membranes of inter- and intralobular excretory ducts,
and of the GCT. Scattered staining for laminin-5 in spin-
dle- or crescent-shaped structures surrounding the acini,
GCT, or striated duct suggested the presence of laminin-5
chain in myoepithelium (Redman, 1994). Clear staining for
the laminin-5 chain was also seen in the walls of small
arteries and nerves in the parenchyma, but not in the cap-
illary basement membranes.
Systematic screening for the effects of laminin-5 G
domain-derived cell-adhesive peptides for in vitro growth
and differentiation of SMG
The localization of laminin-5 in the SMG is consistent
with a role in early epithelial branching morphogenesis. We,
therefore, tested whether laminin-5 G domain peptides,
which supported HT1080 cell adhesion (Table 1) (Makino
et al., 2002), could affect in vitro branching morphogenesis
using the SMG organ culture system. Using a stereoscopic
microscope, the gross morphology of the submandibular
epithelium was assessed in the explants cultured for 3 days
in the presence or absence of 0.19 mM laminin-5 chain G
domain peptides. A clear inhibition of epithelial branching
was apparent in the explants treated with the A5G77 peptide
(Figs. 2B and 3), while other adhesive laminin-5 G domain
peptides failed to show any effect (data not shown). Pep-
tides corresponding to the A5G77 sequence but derived
from laminin-1, -3, or -4 chains (AG76.5, A3G75, and
A4G82; see Table 1) were also tested. Although the cortical
mesenchyme of the explants treated with A4G82 appeared
slightly expanded after 3 days of culture (Fig. 2C), none of
the peptides had an effect on epithelial branching (data not
shown), even at concentrations of 0.53 mM. A5G19 and
A5G109 (Makino et al., 2002) were not soluble in the
medium and were, therefore, not tested.
Active sequence of A5G77
To determine the active sequence within A5G77, amino-
and carboxyl-terminal deletion peptides and a scrambled pep-
tide of A5G77 were synthesized and initially screened for their
ability to support adhesion of HT1080 cells. As shown in Table
2, carboxyl-terminal deletion peptides, A5G77d-f, retained
most of the cell adhesion activity. In contrast, amino-terminal
deletion peptides, A5G77a-c, were less adhesive. A shortened
carboxyl-terminal deletion peptide, A5G77f, was used in the
SMG organ culture assay at different concentrations. A similar
degree of inhibition of epithelial branching was apparent at
Fig. 1. Expression of laminin-5 in the developing and adult mouse SMG as shown by immunofluorescence. Frozen sections were stained with monoclonal
anti-laminin-5-chain antibody (4G6). (A) On E13, the epithelium of the rudimentary SMG consists of several cell clusters connected to a stalk. A continuous
distribution of the laminin-5 chain can be seen in the basement membranes of both the terminal cell clusters (asterisks) and a stalk (arrow). Capillaries are
negative. (B) In newborn SMG, the expression of laminin-5 is seen in the basement membranes surrounding the interlobular (arrow) and intralobular duct
(arrowheads) epithelia. Weak staining is also seen in basement membranes of some acini. Interlobular arteries (double allows) but not veins (asterisk) show
positive staining. (C) In adult mice, localization of laminin-5 is evident in basement membranes of the interlobular excretory duct (double asterisks),
intralobular striated duct (single asterisk), and granular convoluted tubules (GCT, double arrows). The expression of laminin-5 chain is also apparent in star-
or crescent-shaped structures surrounding the acinus, GCT, and striated duct (arrows). Bars, 100 m.
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concentrations of 0.19, 0.25, and 0.53 mM of A5G77f (Figs.
2D and 3). A5G77c was also tested in the organ culture system
at 0.25 mM but failed to interfere with SMG branching. A
scrambled sequence (A5G77fT, Table 2) did not support
HT1080 cell binding or interfere with in vitro SMG morpho-
genesis even at 0.53 mM (Fig. 3).
Fig. 2. Effects of synthetic laminin peptides on in vitro epithelial branching morphogenesis in SMG explants. Rudiments from E13 mice were cultured for
3 days in the absence of peptide (A), and in the presence of 0.19 mM A5G77 (LVLFLNHGHFVA) (B), 0.19 mM A4G82 (TLFLAHGRLVFM) (C), or 0.53
mM A5G77f (LVLFLNHGH) (D). Clear inhibition of epithelial branching is evident in (B) and (D). In (C), no apparent inhibition of epithelial branching
is noted; however, the outer margin of the mesenchyme is extended (C, arrows). Bar, 0.5 mm.
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Morphology of A5G77f-treated SMG rudiment
As shown in Fig. 4A, the terminal end buds of SMG
rudiments treated with 0.25 mM A5G77f for 3 days lost the
smooth contour of normal terminal end buds and were
partially separated by deep clefts. The mesenchyme ap-
peared condensed compared to controls. In the untreated
cultures and cultures grown in the presence of a control
scrambled A5G77fT peptide (0.25 mM), terminal end buds
appeared as rounded structures with only shallow indenta-
tions (Fig. 4B). Immunofluorescence staining for nidogen
revealed continuous basement membrane staining adjacent
to the entire epithelial surface in 3-day-cultured rudiments
treated with 0.53 mM A5G77f peptide (Fig. 4C), with an
amino-terminal deletion peptide A5G77c (Fig. 4D), and
without peptide (data not shown). Transmission electron
microscopy confirmed the presence of intact basement
membranes in the explants treated with 0.19 mM A5G77f
peptide or the same concentration of the control A5G77fT
peptide (Fig. 5).
Effects of A5G77f peptide for kidney and lung organ
cultures
E12 kidney rudiments treated for 3 days with 0.25 mM of
a control scrambled peptide, A5G77fT, grew well and
showed extensive branching of the ureteric bud and normal
tubule formation (Fig. 6A). No difference was observed
between A5G77fT-treated and untreated cultures (data not
shown). In contrast, the rudiments treated with same con-
centration of A5G77f peptide exhibited dramatic perturba-
tion of ureteric bud branching and reduced nephrogenesis
(Fig. 6B and E). Similarly, E11 lung rudiments cultured in
the presence of 0.25 mM A5G77f showed reduced epithelial
branching morphogenesis (Fig. 6D and E), while the control
peptide, A5G77fT, had no effect (Fig. 6C).
Discussion
Localization of laminin-5 in the developing and mature
mouse SMG
We have examined the localization of laminin-5 during
morphogenesis of the mouse SMG using a well-character-
ized antibody, 4G6, revealing its occurrence in all epithelial
basement membranes from the onset of branching morpho-
genesis (E13), and a broad distribution in basement mem-
branes of various epithelial segments of the duct system of
the mature gland. This is in accordance with previous in situ
hybridization studies, which demonstrated strong expres-
sion of laminin-5 mRNA in the developing SMG epithe-
lium (Durbeej et al., 1996; Miner et al., 1997). At these
early stages of development, the laminin-1 also occurs in
epithelial basement membranes of the SMG (Kadoya et al.,
1995). Moreover, a crucial role for laminin-1 and its re-
ceptors in branching morphogenesis was established
through the use of specific antibodies (Durbeej et al., 2001;
Kadoya et al., 1995; Kashimata and Gresik, 1997) or inhib-
itory peptides (Hoffman et al., 2001; Hosokawa et al., 1999;
Kadoya et al., 1998) in the SMG organ culture system. The
question, therefore, arises whether the laminin-5 chain
also plays a role in epithelial branching morphogenesis and,
if so, whether such a role is distinct from that of the lami-
nin-1 chain. However, no blocking antibody for the lami-
nin-5 chain for use in the in vitro organ cultures has been
described to date. To investigate whether laminin-5 plays
a role in epithelial branching morphogenesis in the SMG,
we tested laminin-5 G domain peptides, known to support
HT1080 cell adhesion (Makino et al., 2002), in the SMG
organ culture system. A similar approach was successful in
identifying a functionally significant peptide sequence
(AG73) in laminin-1 involved in epithelial morphogenesis
in both the SMG (Kadoya et al., 1998, Hoffman 2001) and
in hair follicles (Hayashi et al., 2002).
Laminin-5 chain G domain peptide influences epithelial
branching morphogenesis
A 12-amino-acid peptide sequence, LVLFLNHGHFVA
(A5G77), derived from the LG4 module of the G domain of
laminin-5, was found to inhibit epithelial branching mor-
phogenesis. The activity was restricted to LVLFLNHGH, a
9-amino-acid carboxyl-terminal deletion sequence (A5G77f),
as established through the use of various truncated peptides
in SMG organ cultures. A5G77f reduced the number of
terminal end buds to 33% of control values (i.e., 67%
Fig. 3. Numbers of terminal end buds in organ cultures of embryonic SMG.
Rudiments from E13 mice were cultured in serum-free medium with or
without various concentrations of laminin-5 chain-derived peptide
A5G77 (LVLFLNHGHFVA), its carboxyl-terminal deletion peptide
A5G77f (LVLFLNHGH), or a scrambled peptide A5G77fT (LNGVL-
HHLF). The numbers of terminal end buds were counted from photographs
after 3 days in organ culture and expressed as means  S.D.
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inhibition), while the same concentration of AG73, a pre-
viously identified laminin-1 chain LG4-derived peptide,
reduced terminal end buds to 17% of controls (i.e., 83%
inhibition) (Kadoya et al., 1998). Similar reductions in ter-
minal end bud formation in SMG organ cultures have been
reported to occur in the presence of blocking antibodies
against the laminin-1 LG4 module (Mab 200) (Kadoya et
al., 1995), or against laminin receptors, such as integrin-6
subunit (GoH3) (Kadoya et al., 1995) and -dystroglycan
(Durbeej et al., 2001). However, morphological analyses
revealed that A5G77f not only reduced the numbers of
developing terminal end buds, but also altered their mor-
phology in a manner distinct from that observed in the
previous studies. Treatment of SMG rudiments with AG73,
GoH3, Mab 200, or antibody against -dystroglycan, re-
sulted in less branching and terminal end buds with smooth
contours. In contrast, epithelium of SMG organ cultures
treated with A5G77f showed extensive irregularities in their
contour, with formation of deep clefts, indicating inhibition
of outgrowth or elongation of end buds, rather than the
Fig. 4. Histology showing epithelia of the SMG rudiments treated with peptides. (A, B) Toluidine-blue-stained, 1-m plastic sections of the SMG rudiments
cultured for 3 days in the presence of A5G77f (LVLFLNHGH) at 0.25 mM (A) or with the same concentration of control scrambled peptide, A5G77fT
(LNGVLHHLF) (B). Terminal end buds of A5G77f-treated rudiment are partially separated by deep clefts (A, arrows). Arrowhead in (A) indicates a mitotic
cell. In contrast, terminal end buds of the control peptide-treated rudiments are round and only shallow indentations (B, arrows) are seen. Note the tightly
packed mesenchymal cells in (A). (C, D) Immunofluorescence staining for nidogen in the rudiments cultured for 3 days with A5G77f peptide at 0.53 mM
(C) or with the same concentration of an amino-terminal truncated peptide A5G77c (FLNHGHFVA) (D) as shown by confocal laser scanning micrographs.
A continuous basement membrane staining surrounding the entire epithelial surfaces of both A5G77f-treated (C) and control (D) rudiments. Bar, 100 m.
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failure of bifurcation of epithelial clusters. This may indi-
cate a role for laminin-5 in the development of epithelial
duct system of the SMG. Among the laminin-5 peptides
tested, A5G77 was not the most adhesive in HT1080 cell
binding assays (Makino et al., 2002). Moreover, A5G81,
which was formerly called F4 and defines a major heparin
and cell binding site within the laminin-5 LG4 module
(Nielsen et al., 2000), failed to interfere with in vitro SMG
development. Taken together, this suggests that A5G77f
interferes with a specific process that is relevant for SMG
epithelial development, possibly a specific receptor-medi-
ated process.
The crystal structure of the laminin-2 LG5 module has
been resolved (Hohenester et al., 1999). The LG module
consists of a 14-stranded  sheet (A to N) sandwich struc-
ture. A calcium-binding site is mapped to one edge of the
LG module, surrounded by the residues implicated in
-dystroglycan binding (Tisi et al., 2000). When we accom-
modate the A5G77f sequence within this structural model
(Timpl et al., 2000), it forms part of the E strand and the
connecting loop between E and F strands (EF loop), which
is located opposite to the calcium binding site. Recently,
two independent investigations identified two biologically
active peptides, A3G75 and A4G82, which include the EF
loop sequences of LG4 modules of laminin-3 and -4
chains. Interestingly, A3G75 inhibited syndecan-mediated
cell-binding to recombinant laminin-3 LG4 module (Utani
et al., 2001), while A4G82 inhibited heparin- and cell-
Fig. 5. Transmission electron micrographs showing basal surfaces of epithelia of SMG rudiments treated with peptides. Periphery (A) and cleft (B, arrow)
of epithelial end bud of SMG rudiment cultured for 3 days in the presence of 0.19 mM A5G77f (LVLFLNHGH). (C) The outer surface of SMG rudiment
cultured for 3 days with the same concentration of a scrambled peptide, A5G77fT (LNGVLHHLF). Continuous basement membranes along the basal surface
of epithelial tip and cleft are seen in A5G77f-treated (A, B; arrowheads) and in the control (C; arrowheads) explants. Bars, 1 m.
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binding to recombinant laminin-4 LG1-5 (Okazaki et al.,
2002; Yamaguchi et al., 2000). These findings support the
concept that the EF loop of the LG4 module plays a role in
cellular recognition of laminins, via cell surface molecules
with heparin-like activity, such as the syndecans.
Besides syndecans, several different cell surface mole-
cules, including integrin 31, 61, and 64 (Feretta
and Ekblom, 1999; Kikkawa et al., 1998), and Lutheran
blood group glycoprotein (Lu) (Kikkawa et al., 2002; Moul-
son et al., 2001), can bind to the laminin-5. -Dystrogly-
can is also reported to bind to the G domain of laminin-5
(Shimizu et al., 1999), but this binding is contested (Hohe-
nester et al., 1999; Timpl et al., 2000). In epithelial–mes-
enchymal organs, the expression of all these receptors are
essentially found on all epithelial cells (Durbeej et al., 1995;
Kadoya and Yamashina, 1993; Moulson et al., 2001). It is
unlikely that A5G77f primarily interferes with the interac-
tion between laminin-5 and -dystroglycan, or between
laminin-5 and 6-integrin, due to the morphological dif-
ferences in explants treated with the laminin-5 chain pep-
tide and with anti--dystroglycan (Durbeej et al., 2001) or
anti-6-integrin antibodies (Kadoya et al., 1995). The bind-
ing site for Lu has recently been mapped to LG3 module;
thus, it is also unlikely that A5G77f impaired cell recogni-
tion of laminin-5 via Lu receptor (Kikkawa et al., 2002).
Immunoblot experiments of Miner et al. (1997) suggest
that the tissue form of laminin-5 is a mixture of both intact
(450 kDa) and several truncated polypeptides. The specific
binding of monoclonal antibody 4G6 to laminin-5 chain
has been tested only with the intact laminin-5 chain (So-
rokin et al., 1997b) and it is not clear whether it recognizes
truncated forms of the chain. Hence, the present immuno-
fluorescence does not distinguish between the intact and the
truncated forms of the laminin-5 chain. It may be that the
truncation of laminin-5 chain occurs by posttranslational
cleavage within the G domain, as has been shown for the
laminin-2 chain which is cleaved within LG3 module
(Talts et al., 1998), and for laminin-3 (Burgeson, 1996)
and -4 (Talts et al., 2000) chains which are cleaved be-
tween LG3 and LG4 modules. Upon cleavage, the release of
such LG4-5 modules or fragments thereof, carrying pep-
tides such as A5G77 and/or A5G77f, may either remain
associated with the main body of the chain, as has been
shown for laminin-2 (Talts et al., 1998) or as reported for
Fig. 6. Effects of synthetic A5G77f peptide (LVLFLNHGH) on in vitro morphogenesis of E12 kidney and E11 lung. Kidney and lung rudiments were cultured
for 3 days in the presence of control A5G77fT (LNGVLHHLF) (0.25 mM) (A, C) or 0.25 mM A5G77f peptide (B, D). In (E), the numbers of terminal air
sacs or metanephric vesicles were counted and expressed as means S.D. Clear inhibition of epithelial branching is evident in kidney (C) and lung (D) organ
cultures treated with A5G77f. Bars, 0.5 mm.
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laminin-4 (Timpl et al., 2000) become released from the
basement membrane and potentially interact with mesen-
chymal cells. As we also noticed some abnormality in the
mesenchyme of the explants treated with A5G77f, we can-
not rule out the possibility that the A5G77f affects the
mesenchymal cells.
In the present study, A5G77f inhibited the in vitro mor-
phogenesis of SMG, kidney, and lung, suggesting that the
region containing the EF loop of laminin-5 LG4 module
may be involved in the development of various organs. This
is consistent with the multiorgan defects found in Lama5/
mice (Miner et al., 1998), which show a dramatic reduction
in branching of ureteric duct in the kidney (Miner and Li,
2000) and abnormalities in the salivary glands (Miner et al.,
1998). However, no defect in epithelial branching of lung of
Lama5/ mice has been described (Nguyen et al., 2002),
which is probably due to compensation by ectopic expres-
sion of laminin-4 chain in the lung epithelial basement
membranes.
Even though the absence of laminin-5 underlying some
epithelia of Lama5/ mouse embryos results in severe
defects in basement membrane assembly (Miner et al.,
1998), epithelial basement membranes remained continuous
in the A5G77f-treated SMG explants. This may indicate
that the A5G77f portion of the laminin-5 chain is not
important for basement membrane assembly in the SMG,
and/or that the expression of laminin-1 in the embryonic
SMG epithelial basement membranes (Kadoya et al., 1995)
is sufficient for the structural organization of the embryonic
basement membrane. This view is supported by the fact that
perturbation of basement membrane formation in Lama5/
mice was found mainly in basement membranes in which
laminin-1 chain was absent in the normal mice, such as
glomerular basement membrane of capillary loop stage
(Miner and Li, 2000) and visceral pleural basement mem-
brane (Nguyen et al., 2002). It should be pointed out that
impaired basement membrane formation was seen in the
SMG explants treated with a laminin-1 LG4 module pep-
tide AG73 (Kadoya et al., 1998), and a monoclonal antibody
Mab 200 (Kadoya et al., 1995), which has been shown to
interfere -dystroglycan binding to laminin-1 LG4 module
(Durbeej et al., 2001). This suggests a predominant role for
laminin-1, rather than laminin-5, in embryonic basement
membrane assembly in the SMG.
In summary, our data showed that the laminin-5 chain
was deposited in the SMG epithelial basement membrane
from the onset of branching morphogenesis, suggesting a
role in epithelial branching morphogenesis. Laminin-5
chain G domain peptide, LVLFLNHGHFVA (A5G77), and
its carboxyl-terminal deletion 9-amino-acid peptide,
A5G77f, containing a sequence located in the connecting
loop between strands E and F of LG4 module, perturbed
epithelial branching morphogenesis. The epithelial base-
ment membranes of A5G77f-treated explants were intact,
which was in contrast to the impaired basement membrane
formation of the explants treated with a laminin-1 LG4
module peptide, AG73 (Kadoya et al., 1998), and monoclo-
nal antibody against laminin-1 LG4 (Kadoya et al., 1995).
This suggests crucial but distinct roles for the LG4 module
of laminin-1 and -5 chains for branching morphogenesis.
The identity of cell surface molecule that binds to the
A5G77 sequence remains to be determined.
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